🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/2012 | 55,34 | 55,55 | 55,00 | 55,22 | -0,27% | 0,99% | 314.600 |
| 22/08/2012 | 55,30 | 55,65 | 54,71 | 55,37 | +0,20% | 1,70% | 437.000 |
| 21/08/2012 | 56,07 | 56,48 | 55,17 | 55,26 | -1,20% | 2,34% | 584.400 |
| 20/08/2012 | 56,17 | 56,36 | 55,57 | 55,93 | -0,52% | 1,41% | 476.500 |
| 17/08/2012 | 56,33 | 56,49 | 56,03 | 56,22 | -0,12% | 0,82% | 380.900 |
| 16/08/2012 | 56,72 | 56,85 | 56,13 | 56,29 | -0,86% | 1,27% | 472.600 |
| 15/08/2012 | 55,89 | 57,03 | 55,50 | 56,78 | +1,23% | 2,74% | 401.600 |
| 14/08/2012 | 55,53 | 56,35 | 55,37 | 56,09 | +1,15% | 1,76% | 343.700 |
| 13/08/2012 | 55,29 | 55,61 | 54,65 | 55,45 | +0,40% | 1,74% | 378.300 |
| 10/08/2012 | 55,47 | 55,48 | 55,00 | 55,23 | -0,34% | 0,87% | 298.400 |
| 09/08/2012 | 55,01 | 55,65 | 54,89 | 55,42 | +0,51% | 1,38% | 362.300 |
| 08/08/2012 | 55,54 | 55,71 | 54,86 | 55,14 | -0,67% | 1,53% | 387.000 |
| 07/08/2012 | 56,33 | 56,38 | 55,39 | 55,51 | -0,70% | 1,76% | 608.200 |
| 06/08/2012 | 54,34 | 56,24 | 54,22 | 55,90 | +3,48% | 3,72% | 694.800 |
| 03/08/2012 | 54,84 | 55,49 | 53,88 | 54,02 | +0,50% | 2,94% | 1.089.700 |
| 02/08/2012 | 53,49 | 54,26 | 52,72 | 53,75 | -0,54% | 2,88% | 827.100 |
| 01/08/2012 | 55,15 | 55,46 | 54,03 | 54,04 | -1,35% | 2,59% | 572.600 |
| 31/07/2012 | 54,39 | 54,93 | 54,11 | 54,78 | +0,75% | 1,51% | 850.900 |
| 30/07/2012 | 54,78 | 55,45 | 54,24 | 54,37 | -0,38% | 2,21% | 626.900 |
| 27/07/2012 | 52,72 | 54,83 | 52,72 | 54,58 | +3,61% | 4,00% | 666.100 |
| 26/07/2012 | 51,12 | 52,98 | 50,03 | 52,68 | +4,52% | 5,77% | 1.131.000 |
| 25/07/2012 | 50,16 | 50,68 | 49,50 | 50,40 | +1,06% | 2,35% | 655.400 |
| 24/07/2012 | 51,19 | 51,25 | 49,54 | 49,87 | -1,68% | 3,34% | 976.800 |
| 23/07/2012 | 51,49 | 51,73 | 49,99 | 50,72 | -3,32% | 3,38% | 847.800 |
| 20/07/2012 | 53,27 | 53,65 | 52,43 | 52,46 | -1,61% | 2,29% | 699.600 |
| 19/07/2012 | 53,54 | 53,86 | 52,95 | 53,32 | -0,36% | 1,70% | 563.300 |
| 18/07/2012 | 53,27 | 54,66 | 53,10 | 53,51 | +0,41% | 2,93% | 788.800 |
| 17/07/2012 | 52,11 | 53,53 | 52,11 | 53,29 | +2,26% | 2,73% | 737.600 |
| 16/07/2012 | 51,54 | 52,24 | 51,00 | 52,11 | +1,36% | 2,41% | 579.700 |
| 13/07/2012 | 50,75 | 51,49 | 50,22 | 51,41 | +1,58% | 2,50% | 427.100 |